TO THE EDITOR Seborrheic keratoses (SKs) are among the most common benign tumors in humans, occurring in 80-100% of people over 50 years of age (Yeatman et al., 1997; Kwon et al., 2003) . Although not life-threatening, SKs may become irri-tated and itchy, are often unattractive and disfiguring, and may have a significantly negative psychological impact as daily reminders of aging. Several recent studies of the pathogenesis of SK have identified the importance of somatic activating mutations of fibroblast growth factor receptor 3 (FGFR3) (Logie et al., 2005; Hafner et al., 2006a Hafner et al., , b, 2007a and oncogenic mutations of the p110a subunit (PIK3CA) of phosphatidylinositol 3-kinase (PI3K) in an independent distribution (Hafner et al., 2007d (Hafner et al., , 2008 . At the molecular level, PI3K signaling, upstream of AKT (a serine-threonine kinase downstream of PI3K, also called protein kinase B) activation, is negatively regulated by the tumor suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10) (Di Cristofano and Pandolfi, 2000; Suzuki et al., 2003; Backman et al., 2004) . Our recent studies demonstrated that PTEN is downregulated by exposure to both UVB (Ming et al., 2010) and UVA (He et al., 2006) .
Although SKs occur on both sunexposed and non-sun-exposed skin, cumulative exposure to sunlight and aging have been proposed as independent risk factors for their development (Yeatman et al., 1997; Kwon et al., 2003) . Here we report that in mice with a targeted PTEN downregulation in their epidermis, UVA causes the formation of tumors resembling human SKs as well as of squamous cell carcinomas (SCCs).
To determine the role of PTEN in UVA-induced skin tumorigenesis, we compared UVA-induced tumor formation between mice with normal PTEN ( þ / þ ) and mice with PTEN hemizygosity ( þ /À). All animal procedures were approved by the Institutional Animal Care and Use Committee at the University of Chicago. We deleted one allele of the Pten gene in the epidermal keratinocytes by crossbreeding mice expressing Cre recombinase under the control of the keratin 14 promoter (K14-Cre) with mice expressing a LoxPflanked (floxed) Pten gene (Ptenfl/fl) to generate K14-Cre;Ptenfl/ þ (Pten þ /À) (Figure 1a ). To mimic the scenario of low-level UVA exposure that occurs in daily life for most people, we determined that the maximal dose of UVA that did not cause erythema was 15 J cm À2 and used that dose for all UVA experiments. The shaved mice were exposed to UVA or protected from UVA (sham group) for 25 weeks and then monitored for tumor development.
In the absence of UVA, Pten þ / þ and Pten þ /À did not grow tumors throughout the study period. UVA did not cause tumor formation in Pten þ / þ mice. However, Pten þ /À mice began to develop skin tumors at 37 weeks of UVA irradiation (Figure 1b) . A log-rank test showed that PTEN hemizygosity significantly accelerated skin tumorigenesis following UVA irradiation (Po0.0001). Histopathological analysis of the tumors, using similar criteria for mice (Logie et al., 2005; Benavides et al., 2009) , showed that in UVAexposed Pten þ /À mice 67% of the tumors were of the SK type, whereas 33% were SCCs (Figure 1c and d) . Thus, following UVA radiation, PTEN downregulation becomes a predisposing factor for skin tumorigenesis. Similar to the transgenic mouse model with an activating FGFR3 mutation (Logie et al., 2005) , the skin lesions observed in our mouse model share several histological features with human SKs, including acanthosis, hyperkeratosis, papillomatosis, and keratin-filled structures (horn cysts and pseudo-horn cysts) (Figure 1e and f) , while lacking significant cytological atypia, whereas the SCCs are characterized by the presence of atypical nuclei, mitotic figures, and multinucleated cells (Figure 1g and h) .
To determine the molecular mechanisms by which UVA causes SK and SCC in Pten þ /À mice, we carried out immunohistochemical analysis of sham-irradiated epidermis, UVA-irradiated nontumor epidermis, SK, and SCC to investigate whether UVA further reduces the PTEN dose during tumorigenesis (Figure 2a and b) . In Pten þ /À epidermis, UVA irradiation further reduced epidermal PTEN levels (Figure 2c ), consistent with our previous findings (He et al., 2006) . In SKs and SCCs, PTEN levels were further reduced as compared with nonlesional epidermis exposed to UVA or sham-irradiated (Figure 2d and e ). Immunoblot analysis showed that PTEN was significantly downregulated in both UVA-induced SK and SCC (Figure 2f and g) . As compared with normal Pten þ /À skin, AKT phosphorylation was significantly increased in SK and SCC (Figure 2f and h). However, there was no significant difference in either PTEN or AKT phosphorylation between SK and SCC (Figure 2f-h) . These findings suggest that PTEN loss, in which UVA has an active role, is an early event in the development of SK and SCC.
To determine the mechanisms by which UVA causes SK in Pten þ /À mice, we examined the role of the glioma tumor-suppressor candidate region gene 2 (GLTSCR2), a nuclear protein that binds to and stabilizes PTEN (Okahara et al., 2004; Yim et al., 2007) and is reduced in SK (Kim et al., 2010) . Real-time RT-PCR analysis showed that there were no significant differences in GLTSCR2 mRNA levels between þ / þ , þ /À, and SK (Figure 2i ), suggesting that GLTSCR2 is not involved in our SK mouse model. To determine the molecular impact of PTEN downregulation, we examined the phosphorylation of AKT and ERK (extracellular signal-regulated kinase) in parental and PTENdownregulated epidermis. We found that phosphorylation of AKT and ERK in Pten þ / þ skin was increased at 6 and 24 h after 15 J cm À2 UVA irradiation (Figure 2j and Supplementary Figure S1 online). PTEN downregulation significantly increased AKT phosphorylation at both 6 and 24 h following 15 J cm À2 UVA irradiation (Figure 2j and Supplementary Figure S1A online). However, it significantly increased ERK phosphorylation only at 24 h following UVA irradiation ( Figure  2j and Supplementary Figure S1B online). Furthermore, we found that UVA irradiation inhibited cell growth in vitro and in vivo (Figure 2k and Supplementary Figure S2 online). Constitutive PTEN reduction in the epidermis delayed cell exit from UVA-induced growth arrest (Supplementary Figure  S2 online) . While acute re-expression of PTEN in PTEN þ /À keratinocytes had little effect on cell growth post-UVA irradiation in vitro, it significantly inhibited cell growth in sham-irradiated cells (Po0.05) (Figure 2k ). These data indicate that PTEN reduction exerts a critical role in UVA-induced development of SK as well as SCC, probably through the AKT and ERK pathways.
